|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/00 | (2006.01) |
| A61K 39/00 | (2006.01) | ||
| C07K 16/18 | (2006.01) |
| (11) | Number of the document | 2794654 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12859920.6 |
| Date of filing the European patent application | 2012-12-19 | |
| (97) | Date of publication of the European application | 2014-10-29 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-22 |
| (46) | Date of publication of the claims translation | 2019-11-11 |
| (86) | Number | PCT/US2012/070486 |
| Date | 2012-12-19 |
| (87) | Number | WO 2013/096380 |
| Date | 2013-06-27 |
| (30) | Number | Date | Country code |
| 201161577817 P | 2011-12-20 | US |
| (72) |
ALDERFER, Christopher, US
JANECKI, Dariusz, DK
LIU, Xuesong, US
MURDOCK, Melissa, US
WU, Sheng-Jiun, US
MERCKEN, Marc, BE
VANDERMEEREN, Marc, BE
MALIA, Thomas, US
|
| (73) |
Janssen Biotech, Inc.,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-PHF-tau antikūnai ir jų panaudojimas |
| ANTI-PHF-TAU ANTIBODIES AND THEIR USES |
| Payment date | Validity (years) | Amount | |
| 2024-11-22 | 13 | 289.00 EUR |
| 2025-12-19 |